Clinical pathways are known to improve the value of health care in medical and surgical settings but have been rarely studied in the psychiatric setting. This study examined the association between level of adherence to an adolescent depressive disorders inpatient clinical pathway and length of stay (LOS), cost, and readmissions. Patients in the high adherence category had significantly longer LOS and higher costs compared to the low adherence category. There was no difference in the odds of 30-day emergency department return visits or readmissions. Understanding which care processes within the pathway are most cost-effective for improving patient-centered outcomes requires further investigation.
Introduction
In 2008, the Institute for Healthcare Improvement created the Triple Aim, a framework for healthcare performance that emphasizes three dimensions: improving the patient experience of care, improving the health of populations, and reducing the per-capita cost of health care (Berwick et al. 2008) . Hospitals have responded to this charge by more extensively instituting clinical pathways to streamline care, reduce variation, and provide higher quality, more efficient care at lower costs (Chassin et al. 1986; Coffey et al. 1992; Welch et al. 1993) . Clinical pathways serve as a step beyond clinical practice guidelines in that evidence-based recommendations are implemented as a defined set of processes for a particular clinical condition executed by a multidisciplinary team of providers. A recently published meta-analysis demonstrated that clinical pathways significantly reduced inhospital complications and improved clinical documentation without adversely impacting patient care (Rotter et al. 2010) .
In contrast to other care settings where implementation of clinical pathways have been associated with shorter lengths of stay and lower costs of care (Lion et al. 2016; Sylvester and George 2014; Tarin et al. 2014; Varadhan et al. 2010) , evidence regarding the effectiveness of clinical pathways in psychiatric care settings has not been well established, and largely consists of studies in adult and geriatric populations (Desplenter et al. 2009; Emmerson et al. 2006; Evans-Lacko et al. 2008; Nakanishi et al. 2010) . Two pediatric studies examined the impact of clinical pathways on health outcomes and health care utilization in adolescent psychiatric inpatients (Greenham and Bisnaire 2008; Lock 1999) . One study found that a clinical pathway for adolescent inpatients with anorexia nervosa was associated with improved target weight gain during admission and a longer length of stay (Lock 1999) . Another study found that improvement in patient acuity level over the course of inpatient treatment was similar among patients receiving varying levels of a generic inpatient psychiatric treatment pathway (Greenham and Bisnaire 2008) . However, the impact of adherence to specific care processes within clinical pathways 1 3 on healthcare utilization outcomes has not been critically evaluated in adolescent patients with depressive disorders. This study aimed to examine the association between the level of staff adherence to an adolescent depressive disorders clinical pathway, length of stay, costs of care, and readmission rates. Based on results from studies performed in the non-psychiatric setting (Bryan et al. 2017; Lion et al. 2016) , we hypothesized that higher staff adherence to the clinical pathway would be associated with shorter length of stay, lower costs of care, and fewer readmissions.
Method

Study Design and Population
We conducted a retrospective cohort study utilizing clinical and healthcare utilization data from patients admitted to the Psychiatry and Behavioral Medicine Unit (PBMU) of a 350-bed pediatric tertiary care facility, between January 1st, 2014, and May 31st, 2015. Only patients who were eligible for the Adolescent Depressive Disorders Clinical Pathway were included in the cohort. Patients were eligible for the pathway if the met the following criteria: (1) 10-18 years of age and (2) diagnosed with a depressive disorder including major depression; depression, not otherwise specified; dysthymia; or adjustment disorder with depressed mood. Patients were excluded from the pathway if they were diagnosed with mania, psychosis, or developmental delay. We excluded any inpatient stays in which the patient was not directly admitted to the PBMU to ensure that measured outcomes were reflective of care received only in the PBMU while the patient was on the clinical pathway. We also excluded inpatient stays that occurred within 30 days of a prior PBMU admission to minimize the impact of pathway care from the previous admission on the measured outcomes.
Predictors
Level of Adherence to the Adolescent Depressive Disorders Clinical Pathway
The Adolescent Depressive Disorders Clinical Pathway is composed of 13 processes of care that address intake, diagnostic formulation, treatment decisions, and discharge planning (Table 1) . The pathway was developed by a multi-stakeholder group of psychiatrists, psychologists, subspecialty providers, nurses, pharmacists, and clinical effectiveness administrators based on evidence from published studies, systematic reviews and guidelines relating to best practices for the diagnosis and treatment of depression (Birmaher et al. 1998; Cheung et al. 2007 ; National Collaborating Centre for Mental Health 2010; Erford et al. 2011; Hazell 2003; Henken et al. 2007; Jorm et al. 2008; Larun et al. 2006; National Guideline Clearinghouse 2010; New Zealand Ministry of Health 2008 , US Preventive Services Task Force 2009 Williams et al. 2009; Zuckerbrot et al. 2007 ). However, due to the paucity of evidence related to effective inpatient care of pediatric patients with depressive disorders, many of the processes of care were based on expert consensus. The process of how pathways are developed and implemented at this institution is described in detail elsewhere (Lion et al. 2016) .
For each inpatient stay, the PBMU staff recorded whether individual processes of care were completed using a standard electronic form that was stored in an internal PBMU database. Level of staff adherence to the clinical pathway was determined using the following protocol. First, processes of care that were noted to be completed by PBMU staff in the internal database were coded as "1 = completed". Next, processes of care that were recorded as incomplete were further examined based on the reason for non-completion. Two research team members and the PBMU medical director first independently categorized reasons for non-completion into two categories, and then met to resolve any disagreements in categorization. The first category included reasons for noncompletion that were due to a failure on the part of the PBMU (e.g. not enough clinical resources to complete the process of care or the team declined to complete the process of care). In these cases, patients were assigned a score of "0 = not completed" for that specific process of care. The second category included reasons for non-completion that were related to factors outside of the control of PBMU staff (e.g. patient refused to complete the process or the caregiver was unable to attend a required meeting). In these cases, patients were deemed ineligible for that specific process of care. This approach was used to ensure level of adherence to the clinical pathway was reflective of processes of care that were reasonable to complete by PBMU staff. For each inpatient stay, level of adherence scores were computed on a 0-100 scale, by calculating the sum of completed processes of care divided by the number of processes of care for which the patient was eligible and multiplying by 100. The adherence score therefore reflects the behaviors of the clinical staff members in implementing the processes of care during the patient's inpatient stay. Higher adherence scores reflected better staff adherence to the pathway. We placed each inpatient stay into one of three categories: low adherence (score < 83), medium adherence (score 83-99), and high adherence (score 100) based on the tertile distribution of scores (i.e. each category included 33% of the total inpatient stays).
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Covariates
Insurance status and medical complexity were included as covariates, as these were a priori thought to be associated with both staff adherence to the clinical pathway and the measured outcomes (Cohen et al. 2012; Simon et al. 2010; Todd et al. 2006) . Insurance status was collapsed into two categories for analysis: public insurance (including Medicaid, military insurance and self-pay) or private insurance. Medical complexity was determined using the Pediatric Medical Complexity Algorithm (Simon et al. 2014 ) which classifies patients as having no chronic illness (e.g. febrile seizure), noncomplex chronic illness (e.g. epilepsy), or complex chronic illness (e.g. epilepsy with chronic respiratory 
Outcomes
Measured outcomes included inpatient length of stay (LOS), costs of care, 30-day emergency department (ED) return visits, and unplanned 30-day inpatient readmissions, which were all obtained from hospital administrative data. Given their skewed distributions, LOS and cost variables were winsorized at the 99th percentile. Accordingly, five inpatient stays with LOS > 26.7 days were assigned a LOS of 26.7 days and five inpatient stays with cost > $71,605 were assigned a cost of $71,605. Costs were obtained from our internal cost accounting system, Allscripts EPSi (Allscripts Healthcare Solutions, Chicago, IL) using industry standard cost to charge ratios. All costs were inflation-adjusted to 2014 dollars using the medical care services component of the Consumer Price Index (Basu 2017 ; Bureau of Labor Statistics 2013). Readmissions were marked as unplanned using the guidelines developed by Berry et al. (2013) . All study procedures were reviewed and approved by the hospital research institute's Institutional Review Board.
Statistical Analysis
Univariate and multivariate generalized linear models were used to examine the association between adherence category and LOS and cost as continuous variables. Models examining LOS as the dependent variable used a Poisson family and a log link, and were adjusted for insurance status and medical complexity. Models examining cost as the dependent variable used a gamma family and a log link, as is typical of analyses of economic data, and were adjusted for insurance status, medical complexity, and LOS as a continuous variable (Drummond et al. 2015) . The appropriate family was chosen using the Modified Park test (Buntin and Zaslavsky 2004; Manning and Mullahy 2001) . Univariate and multivariate linear regression models were used to examine the association between completion of each process of care and LOS or cost. Models were adjusted for the same covariates as noted above. Multivariate logistic regression models were used to measure the association between adherence category and dichotomous 30-day ED return visit and 30-day inpatient readmission variables, adjusting for insurance status and medical complexity. We did not conduct Bonferroni adjustments for multiple comparisons, as this method assumes that the outcomes are independent. Because our outcomes are expected to be correlated with each other, this correction would be too conservative. All analyses were conducted in Stata version 12 (StataCorp 2011).
Results
Descriptive Statistics
The study sample included 529 inpatient stays. Patients were predominantly aged 13-15, female, White, privately insured, and in the non-complex chronic medical complexity category ( Table 2 ). The mean clinical pathway adherence score for the total sample was 82.0 (SD 22.4), with a mean score of 55.6 (SD 20.8) for the low adherence group and 100.0 (SD 0.0) for the high adherence group. A significantly higher proportion of publically insured patients were in the low adherence group compared to the high adherence group. Completion percentages for each process of care for the low adherence category are presented in Table 1 . Completion percentages were highest (> 90%) for the following processes: (1) collected outside medical records, (2) completed safety planning, and (3) formulated crisis prevention plan.
Association Between Level of Adherence and LOS and Cost
Unadjusted and adjusted differences in LOS and cost by adherence category are presented in Table 3 . Patients in the high adherence category had significantly longer LOS and significantly higher costs than patients in the low adherence category in both the unadjusted and adjusted analyses (adjusted differences and 95% CIs: LOS-1.1 days [95% CI 0.3, 1.9 days], cost-$1285 [95% CI $588, $1982]). The unadjusted and adjusted differences in LOS and cost by individual process of care completion are presented in Tables 4 and 5 . Ten of the processes of care were significantly associated with longer LOS. Completion of patient care tasks (such as completing the "Mood Monitoring and Activity Chart") and formulating a crisis prevention plan were associated with the largest differences in LOS. Nine processes of care were significantly associated with higher cost in unadjusted analyses; however, these results were no longer significant after adjusting for insurance, medical complexity and LOS.
Association Between Process of Care and ED Return Visits and Readmissions
Only 38 inpatient stays resulted in a 30-day return ED visit and 26 inpatient stays resulted in a 30-day inpatient readmission. There was no significant difference in the unadjusted odds of a 30-day ED return visit (OR 
Discussion
This study is the first to examine the association between level of staff adherence to an adolescent depressive disorders inpatient clinical pathway and utilization outcomes. Our findings in a retrospective cohort of adolescent patients with depressive disorders demonstrate that higher staff adherence to a clinical pathway resulted in longer inpatient stays and higher associated costs of care. The study findings were contrary to our hypothesis that higher adherence to a clinical pathway would result in shorter LOS. We hypothesized that implementing the care pathway would streamline care, thus allowing providers to avoid unnecessary interventions and provide more efficient care. This hypothesis was supported by a number of studies from non-psychiatric settings examining resource utilization in medical and surgical settings which have shown a decrease in resource utilization with the implementation of clinical pathways (Bryan et al. 2017; Lion et al. 2016; Stephen and Berger 2003; Sylvester and George 2014; Tarin et al. 2014; Varadhan et al. 2010 ). However, it may be that implementation of the adolescent depressive disorders clinical pathway actually added more care processes to the previous work-flow, thus increasing the time needed to complete the recommended care. These results are consistent with a study conducted in a psychiatric setting that found that implementation of an adolescent psychiatric clinical pathway for patients with anorexia nervosa resulted in longer LOS for all patients (Lock 1999) . Therefore, in the case of ($18,912, $20,689) 1 3 psychiatric care, it may simply be that achieving higherquality care requires implementation of more care processes which takes more time.
In regards to demographic variables that may have contributed to this finding between adherence and LOS, we found there were a significantly larger proportion of publically-insured patients in the low adherence category compared to the high adherence category in this study sample (Table 2) . However, adjusting for insurance status did not alter the association between level of adherence to the clinical pathway and LOS. This suggests that insurance status, which could potentially impact the number of days a patient Table 5 Difference in cost based on process of care completion *P < .05; **P < .01; ***P < .001 a Positive values reflect higher costs for patients who received the process of care compared to patients who did not receive the process of care is approved to stay in the hospital, does not appear to be an explanatory variable for the association between higher adherence on the clinical pathway and longer LOS. In contrast to our initial hypothesis, higher adherence to the clinical pathway was also associated with higher costs, even after adjusting for differences in LOS. We hypothesized that the pathway would minimize extraneous care and therefore decrease costs, but pathway implementation may have actually increased the amount of care being provided to each patient, thus resulting in higher costs for patients in the high adherence group. This is in contrast to clinical pathways for conditions such as bronchiolitis, where healthcare providers are urged to minimize unnecessary care (Barben et al. 2008; Bryan et al. 2017; Mittal et al. 2014) .
A strength of this study is that we identified the magnitude of association between individual processes of care and outcomes. For example, some of the largest differences in LOS were seen between patients who did and did not complete any psychotherapy models (Table 4) . Although providing these processes of care within a longer time-frame may be justifiable for patients to fully process the material presented in these modules, healthcare providers may want to consider starting these processes earlier in the hospitalization or explore ways to complete them more efficiently. However, if completion of these modules is proven to be effective only if given sufficient time to complete them, this may provide justification for reimbursement for longer LOS in order to receive effective, high-quality care.
Although the findings of this study demonstrate that patients who receive more clinical pathway care for adolescent depressive disorders have longer LOS and higher costs of care, more clinical pathway care may translate to improvements in as-yet unmeasured clinical outcomes. For example, a study of an adolescent psychiatric clinical pathway for patients with anorexia nervosa found that although patients on the pathway had longer LOS and higher cost, all of the patients in the last 20 months of the study met their clinical weight gain goals (Lock 1999) . Therefore, we may be able to accept a degree of higher overall costs if improvements in clinical outcomes outweigh the higher cost of care, thus increasing value. In an attempt to address this question, we did examine 30-day ED return visits and 30-day unplanned inpatient readmissions as clinical outcomes; however, due to their rarity of occurrence, we were underpowered to detect any difference in these outcomes between the low and high adherence categories. Demonstrating higher value may also be achieved by measuring patient-reported outcomes (PROs) such as health-related quality of life and functional status (Calla et al. 2007) . PROs or patient experience measures (such as patient-provider communication), may help to determine whether the clinical pathway actually improved the patients' health and sense of well-being (Hostetter and Klein 2012) . In light of the goal of PROs, it seems especially important to include them as a component of psychiatric care pathway evaluation. In future analysis, by linking these pathway processes of care to outcomes such as PROs, we may begin to understand and recommend processes of care that yield the highest value to the patient.
The implementation and evaluation of the Adolescent Depressive Disorders Clinical Pathway may also serve as a guide to development of similar pathways at other institutions as the pathway was created using an evidence-based, multidisciplinary approach. Rigorous evaluation of the effectiveness of these pathways requires careful documentation of processes of care and this should be instituted from the outset, as some of these care processes have more fluid start and end points, which may make documentation difficult or onerous. Furthermore, the following interventions may lead to improved staff adherence to processes of care that were noted to have low adherence in this study: (1) embedding computerized orders or alerts into the electronic medical record to prompt staff to complete certain processes; (2) explicitly linking certain processes of care to routine events during the inpatient stay such as the admission process or reoccurring educational sessions; and (3) hiring dedicated staff to complete certain processes such as psychoeducation. Additionally, psychiatric units planning to implement similar pathways may consider collecting PROs pre-and post-implementation of the pathway to better understand how the clinical pathway impacts the value of care that is being provided. Finally, the pathway should be continually reviewed and revised to improve efficiency in care delivery and eliminate care processes that do not improve clinical outcomes to justify any increase in costs associated with providing more care.
Limitations
This study was conducted at a single institution, which may limit the generalizability of results; however, the study institution was likely representative of other large tertiary children's hospitals with a large referral base. Process of care completion was based on staff-reported data which may have resulted in misclassification of whether processes were truly completed or not; however, this limitation may be acceptable given that level of adherence to these types of care processes cannot be ascertained from administrative data (such as laboratory or billing data). Although we used the PMCA as a measure of medical complexity, we did not have a measure of patient severity of illness at the time of admission, which may have been a predictor of level of adherence to the clinical pathway or the measured outcomes. Additionally, we were underpowered to detect differences in 30-day ED return visits and 30-day readmissions between adherence categories due to the small number of patients who experienced these events. Finally, due to the retrospective 1 3 cohort study design, we were only able to examine the correlation between higher level of adherence and longer LOS. An alternative interpretation of this result is that longer inpatient stays afford more time for clinical staff to complete processes of care.
Conclusions
Patients who received care with high adherence to an adolescent depressive disorders clinical pathway in the inpatient setting incurred a longer LOS and higher costs of care. Adherence to the clinical pathway was not associated with ED return visits or readmissions; however, we may have been underpowered to detect such differences in this study. This study contributes to the limited existing literature on adolescent depressive disorder care in the inpatient setting by providing a set of care processes that were developed using an evidence-based, multidisciplinary approach; providing a greater understanding of key drivers of LOS and cost associated with these processes of care, as well as standards around minimum LOS and cost needed to complete the recommended care for these patients. Future studies should examine the impact of these clinical pathways on clinical outcomes such as PROs to determine how to maximize the value of care for adolescents who are evaluated and treated for depression in the hospital setting. 
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